Literature DB >> 34465625

Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.

Soon-Keat Ooi1, Shigeo Sato1, Chieri Tomomori-Sato1, Ying Zhang1, Zhihui Wen1, Charles A S Banks1, Michael P Washburn1,2, Jay R Unruh1, Laurence Florens1, Ronald C Conaway1,3, Joan W Conaway4,3.   

Abstract

The SNF2 family ATPase Amplified in Liver Cancer 1 (ALC1) is the only chromatin remodeling enzyme with a poly(ADP-ribose) (PAR) binding macrodomain. ALC1 functions together with poly(ADP-ribose) polymerase PARP1 to remodel nucleosomes. Activation of ALC1 cryptic ATPase activity and the subsequent nucleosome remodeling requires binding of its macrodomain to PAR chains synthesized by PARP1 and NAD+ A key question is whether PARP1 has a role(s) in ALC1-dependent nucleosome remodeling beyond simply synthesizing the PAR chains needed to activate the ALC1 ATPase. Here, we identify PARP1 separation-of-function mutants that activate ALC1 ATPase but do not support nucleosome remodeling by ALC1. Investigation of these mutants has revealed multiple functions for PARP1 in ALC1-dependent nucleosome remodeling and provides insights into its multifaceted role in chromatin remodeling.

Entities:  

Keywords:  CHD1L; SNF2 family ATPase; nucleosome binding; nucleosome remodeling; poly(ADP-ribose) synthesis

Mesh:

Substances:

Year:  2021        PMID: 34465625      PMCID: PMC8433585          DOI: 10.1073/pnas.2107277118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.

Authors:  Hari R Singh; Aurelio P Nardozza; Ingvar R Möller; Gunnar Knobloch; Hans A V Kistemaker; Markus Hassler; Nadine Harrer; Charlotte Blessing; Sebastian Eustermann; Christiane Kotthoff; Sébastien Huet; Felix Mueller-Planitz; Dmitri V Filippov; Gyula Timinszky; Kasper D Rand; Andreas G Ladurner
Journal:  Mol Cell       Date:  2017-12-07       Impact factor: 17.970

2.  Development of a novel cross-linking strategy for fast and accurate identification of cross-linked peptides of protein complexes.

Authors:  Athit Kao; Chi-li Chiu; Danielle Vellucci; Yingying Yang; Vishal R Patel; Shenheng Guan; Arlo Randall; Pierre Baldi; Scott D Rychnovsky; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

3.  Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler.

Authors:  Aaron J Gottschalk; Gyula Timinszky; Stephanie E Kong; Jingji Jin; Yong Cai; Selene K Swanson; Michael P Washburn; Laurence Florens; Andreas G Ladurner; Joan W Conaway; Ronald C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

4.  Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.

Authors:  Soon-Keat Ooi; Shigeo Sato; Chieri Tomomori-Sato; Ying Zhang; Zhihui Wen; Charles A S Banks; Michael P Washburn; Jay R Unruh; Laurence Florens; Ronald C Conaway; Joan W Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

5.  Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution.

Authors:  Curt A Davey; David F Sargent; Karolin Luger; Armin W Maeder; Timothy J Richmond
Journal:  J Mol Biol       Date:  2002-06-21       Impact factor: 5.469

6.  The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment.

Authors:  Szilvia Juhász; Rebecca Smith; Tamás Schauer; Dóra Spekhardt; Hasan Mamar; Siham Zentout; Catherine Chapuis; Sébastien Huet; Gyula Timinszky
Journal:  Sci Adv       Date:  2020-12-18       Impact factor: 14.136

7.  Structural studies of the PARP-1 BRCT domain.

Authors:  Paul A Loeffler; Matthew J Cuneo; Geoffrey A Mueller; Eugene F DeRose; Scott A Gabel; Robert E London
Journal:  BMC Struct Biol       Date:  2011-10-03

8.  Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.

Authors:  Laura C Lehmann; Graeme Hewitt; Shintaro Aibara; Alexander Leitner; Emil Marklund; Sarah L Maslen; Varun Maturi; Yang Chen; David van der Spoel; J Mark Skehel; Aristidis Moustakas; Simon J Boulton; Sebastian Deindl
Journal:  Mol Cell       Date:  2017-12-07       Impact factor: 19.328

9.  Transgenic CHD1L expression in mouse induces spontaneous tumors.

Authors:  Muhan Chen; Jian-dong Huang; Liang Hu; Bo-jian Zheng; Leilei Chen; Sze Lan Tsang; Xin-yuan Guan
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

10.  ALC1/eIF4A1-mediated regulation of CtIP mRNA stability controls DNA end resection.

Authors:  Fernando Mejías-Navarro; Guillermo Rodríguez-Real; Javier Ramón; Rosa Camarillo; Pablo Huertas
Journal:  PLoS Genet       Date:  2020-05-11       Impact factor: 5.917

View more
  2 in total

1.  Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.

Authors:  Soon-Keat Ooi; Shigeo Sato; Chieri Tomomori-Sato; Ying Zhang; Zhihui Wen; Charles A S Banks; Michael P Washburn; Jay R Unruh; Laurence Florens; Ronald C Conaway; Joan W Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 2.  The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.

Authors:  Dan Huang; W Lee Kraus
Journal:  Mol Cell       Date:  2022-03-09       Impact factor: 19.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.